MORRISVILLE, N.C.--(BUSINESS WIRE)--etrials® Worldwide, Inc. (Nasdaq: ETWC, ETWCW, ETWCU), a leading provider of eClinical software and services that optimize clinical-trial management and accelerate time-to-market, announced that it has been awarded four new projects with existing pharmaceutical customers worth, in aggregate, $1.7 million over the next three years.
